准核外组织蛋白来缓解急性和慢性炎症
Gerry A F Nicolaes1, Oliver Soehnlein2
1Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), University of Maastricht, The Netherlands.
Trends in pharmacological sciences
|June 9, 2024
概括
细胞外组织素驱动炎症,影响诸如败血症和心血管疾病等疾病. 治疗策略正在出现,以阻止这些有害的激素效应,提供新的治疗可能性.
科学领域:
- 生物医学科学 生物医学科学
- 免疫学 免疫学 免疫学
- 病理生理学 病理生理学
背景情况:
- 细胞外组织蛋白是炎症的关键媒介体,有助于细胞毒性,免疫细胞激活和凝固.
- 这些组织蛋白在各种炎症性疾病中起着重要作用,往往具有有害的结果.
- 细胞外组织素的作用很少,这促使人们对干扰策略的研究.
研究的目的:
- 审查细胞外组织蛋白的致病功能.
- 突出目前干扰细胞外组织素的治疗策略.
- 讨论在败血症和心血管疾病中向细胞外组织素的临床前发展.
主要方法:
- 关于细胞外组织蛋白的病原性功能的文献综述.
- 对当前治疗干扰策略的分析.
- 对败血症和心血管疾病的临床前数据的评估.
主要成果:
- 细胞外基因组诱导有害的炎症反应,包括细胞毒性,免疫刺激和凝血.
- 一些治疗策略正在开发中,以中和细胞外组织素.
- 临床前研究表明,在败血症和心血管疾病中准细胞外组织素具有前景.
结论:
- 细胞外组织蛋白是炎症病理的关键驱动因素.
- 治疗干扰细胞外组织素是一种有前途的方法来治疗炎症性疾病.
- 向细胞外组织蛋白具有管理毒症和心血管疾病的潜力,这是全球主要的健康威胁.
相关概念视频
Inflammatory Response
2.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.0K
Chromatin Modification in iPS Cells
1.6K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.6K
Inflammation
53.3K
Overview
53.3K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
130
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
130
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Spreading of Chromatin Modifications
8.3K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.3K


